Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.
(Bloomberg) -- Novo Nordisk A/S’s once-weekly insulin failed to get approval from ... daily injections and reduce waste from injection pens. In the US, about 1.7 million people have type 1 ...
Novo Nordisk employs around 30,000 people in Denmark ... and type-2 diabetes patients that it had scaled back making insulin pens in South Africa. Without those pens, type 1 diabetics had to ...
The European Commission has granted marketing authorisation for Novo Nordisk’s adult diabetes ... company’s latest prefilled insulin pen, FlexTouch, which has an easy auto-injector mechanism.
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...
The global insulin delivery pen market is poised for remarkable growth, with its valuation projected to increase from USD ...
In 2023, the global disposable pen injectors market is expected to be worth USD 25.5 billion. The market is expected to reach USD 54.4 billion by 2033, expanding at a 7.9% CAGR throughout the forecast ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback